Efficacy and safety of linagliptin in Hispanic/Latino patients with type 2 diabetes mellitus: a pooled analysis from six randomized placebo-controlled phase 3 trials

OBJECTIVE: The number of individuals diagnosed with type 2 diabetes mellitus is expected to rise disproportionately in Hispanic/Latino populations. We therefore aimed to assess the efficacy and safety of the dipeptidyl peptidase-4 inhibitor linagliptin specifically in Hispanic/Latino patients with t...

Descripción completa

Detalles Bibliográficos
Autores principales: Davidson, Jaime A, Lajara, Rosemarie, Aguilar, Richard B, Mattheus, Michaela, Woerle, Hans-Juergen, von Eynatten, Maximilian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Perspectives in Diabetes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212575/
https://www.ncbi.nlm.nih.gov/pubmed/25452864
http://dx.doi.org/10.1136/bmjdrc-2014-000020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212575/
https://www.ncbi.nlm.nih.gov/pubmed/25452864
http://dx.doi.org/10.1136/bmjdrc-2014-000020

Ejemplares similares